Chemo Drug, Xeloda, May Buy Time for Those With Bile Duct Cancer

THURSDAY, May 18, 2017 — The chemotherapy drug Xeloda may prolong survival in those struck by a type of digestive system cancer, a new study finds.
People with bile duct cancer who received the medication lived for an average of about 17 months…
Source: Topamax